Microbot Medical's LIBERTY pivotal study published in JVIR; full market launch in April 2026

Microbot Medical Inc.

ACCESS-PVI study published in JVIR, a top radiology journal, after independent peer review.
LIBERTY received FDA clearance in Sep 2025; limited market release started late 2025.
Full commercial launch planned at SIR conference in April 2026 to expand adoption.
Dr. Francois Cornelis, first author, was Lead PI for the multicenter feasibility study.
LIBERTY is first FDA-cleared single-use robotic system for peripheral endovascular procedures.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-012281
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-03-24T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.911636+00:00
generated_at: 2026-05-15T09:18:24.703391+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-012281
json_url: https://secwatch.observer/filing/0001493152-26-012281.json
markdown_url: https://secwatch.observer/filing/0001493152-26-012281.md
text_url: https://secwatch.observer/filing/0001493152-26-012281.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226012281/0001493152-26-012281-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226012281/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-012281

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.